Author

Jenna Oberg

Children's Hospital of PhiladelphiaORCID 0009-0009-5246-2278Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2

Frequent Co-Authors

Amrita SarkariD· 2 shared Hyun‐Jun KimiD· 2 shared Kandace L. GollompiD· 2 shared Lubica RauovaiD· 2 shared Mortimer PoncziD· 2 shared Abigail E Skidmore· 1 shared Anh T. P. NgoiD· 1 shared Caroline J. DiorioiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Amrita SarkarORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintNov 7, 2025

Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorder

Conroy O. Field, Amrita Sarkar, Khalil H. Bdeir…·Mortimer Poncz

This study identifies PF4 as a central factor in APS by showing it bridges {beta}2GPI to NETs, forming prothrombotic complexes that are targeted by APS antibodies.

2 citations

mouseexperimental assay

𝕏 PostBluesky

Cell BiologybioRxivPreprintSep 2, 2025

Platelet factor 4 modulates endothelial cell antimicrobial activity to enhance bacterial clearance and improve sepsis outcomes

Anh T. P. Ngo, Weronika Ortmann, Abigail E Skidmore…·Kandace L. Gollomp

This study identifies platelet factor 4 (PF4) as a mediator of endothelial antimicrobial activity, enhancing bacterial clearance and improving sepsis outcomes through clathrin-mediated endocytosis and reduced immunothrombosis.

DOI 10.1101/2025.09.02.673783

mouseexperimental assay

𝕏 PostBluesky